Meeting of the National Vaccine Advisory Committee, 60694 [2023-18994]

Download as PDF 60694 Federal Register / Vol. 88, No. 170 / Tuesday, September 5, 2023 / Notices TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of respondents Form name Institution/Loan Repayment Employment Form .................. Authorization to Release Information Form ......................... Disadvantaged Background Form ....................................... * 215 215 215 Total .............................................................................. 860 Number of responses per respondent Average burden per response (in hours) Total responses 1 1 1 215 215 215 Total burden hours 1.00 .25 .20 215.00 53.75 43.00 526.75 * Respondents for this form is the institution on behalf of the applicant. HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2023–19054 Filed 9–1–23; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee Office of Infectious Disease and HIV/AIDS Policy, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) hereby gives notice that the National Vaccine Advisory Committee (NVAC) will hold an inperson meeting. The meeting will be open to the public and public comment will be heard during the meeting. DATES: The meeting will be held September 21–22, 2023. The confirmed meeting times and agenda will be posted on the NVAC website at https:// www.hhs.gov/nvpo/nvac/meetings/ index.html as soon as they become available. ddrumheller on DSK120RN23PROD with NOTICES1 SUMMARY: Instructions regarding attending this meeting will be posted online at: https://www.hhs.gov/nvpo/ nvac/meetings/ at least one week prior to the meeting. Preregistration is required for those who wish to attend the meeting in person or ADDRESSES: VerDate Sep<11>2014 18:02 Sep 01, 2023 Jkt 259001 participate in public comment. Please register at https://www.hhs.gov/nvpo/ nvac/meetings/. FOR FURTHER INFORMATION CONTACT: Ann Aikin, Acting Designated Federal Officer, Office of Infectious Disease and HIV/AIDS Policy, U.S. Department of Health and Human Services, Tower Building, Room, 1101 Wootton Parkway, Rockville, MD 20852. Email: nvac@hhs.gov. Phone: 202–795–7697. SUPPLEMENTARY INFORMATION: Pursuant to section 2101 of the Public Health Service Act (42 U.S.C. 300aa–1), the Secretary of HHS was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The NVAC was established to provide advice and make recommendations to the Director of the National Vaccine Program on matters related to the Program’s responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. During this meeting, NVAC will hear presentations to support the recent charges on innovation and safety from Admiral Rachel L. Levine, MD, the Assistant Secretary for Health and Director of the National Vaccine Program. NVAC will also hear presentations on the actions and strategies taken to better address the unique vaccination needs of people with disabilities, respiratory disease prevention plans for the upcoming fall season, and updates on climate change vaccines. Please note that agenda items are subject to change, as priorities dictate. Information on the final meeting agenda will be posted prior to the meeting on the NVAC website: https:// www.hhs.gov/nvpo/nvac/. Members of the public will have the opportunity to provide comment at the NVAC meeting during the public comment period designated on the agenda. Public comments made during the meeting will be limited to three minutes per person to ensure time is PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 allotted for all those wishing to speak. Members of the public may also submit written comments. Written comments should not exceed three pages in length. Individuals planning to submit comments should email their written comments or their request to provide a comment during the meeting to nvac@ hhs.gov at least five business days prior to the meeting. Dated: August 7, 2023. Ann Aikin, Acting Designated Federal Official, Office of the Assistant Secretary for Health. [FR Doc. 2023–18994 Filed 9–1–23; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Research Misconduct AGENCY: ACTION: Office of the Secretary, HHS. Notice. Findings of research misconduct have been made against Ivana Frech, Ph.D. (formerly Ivana De Domenico) (Respondent), former Assistant Professor, Department of Internal Medicine, University of Utah (UU) School of Medicine. Respondent engaged in research misconduct in research supported by U.S. Public Health Service (PHS) funds, specifically National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), grants R01 DK070947, R01 DK090257, and R01 DK030534, National Institute of General Medical Sciences (NIGMS), NIH, grant P50 GM082545, National Institute of Allergy and Infectious Diseases (NIAID), NIH, grant R01 AI051174, and National Heart, Lung, and Blood Institute (NHLBI), NIH, grant R01 HL026922. The administrative actions, including debarment for a period of three (3) years, were implemented beginning on August 21, 2023, and are detailed below. SUMMARY: E:\FR\FM\05SEN1.SGM 05SEN1

Agencies

[Federal Register Volume 88, Number 170 (Tuesday, September 5, 2023)]
[Notices]
[Page 60694]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-18994]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Office of Infectious Disease and HIV/AIDS Policy, Office of the 
Assistant Secretary for Health, Office of the Secretary, Department of 
Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) hereby gives notice that 
the National Vaccine Advisory Committee (NVAC) will hold an in-person 
meeting. The meeting will be open to the public and public comment will 
be heard during the meeting.

DATES: The meeting will be held September 21-22, 2023. The confirmed 
meeting times and agenda will be posted on the NVAC website at https://www.hhs.gov/nvpo/nvac/meetings/ as soon as they become 
available.

ADDRESSES: Instructions regarding attending this meeting will be posted 
online at: https://www.hhs.gov/nvpo/nvac/meetings/ at least 
one week prior to the meeting. Pre-registration is required for those 
who wish to attend the meeting in person or participate in public 
comment. Please register at https://www.hhs.gov/nvpo/nvac/meetings/.

FOR FURTHER INFORMATION CONTACT: Ann Aikin, Acting Designated Federal 
Officer, Office of Infectious Disease and HIV/AIDS Policy, U.S. 
Department of Health and Human Services, Tower Building, Room, 1101 
Wootton Parkway, Rockville, MD 20852. Email: [email protected]. Phone: 202-
795-7697.

SUPPLEMENTARY INFORMATION: Pursuant to section 2101 of the Public 
Health Service Act (42 U.S.C. 300aa-1), the Secretary of HHS was 
mandated to establish the National Vaccine Program to achieve optimal 
prevention of human infectious diseases through immunization and to 
achieve optimal prevention against adverse reactions to vaccines. The 
NVAC was established to provide advice and make recommendations to the 
Director of the National Vaccine Program on matters related to the 
Program's responsibilities. The Assistant Secretary for Health serves 
as Director of the National Vaccine Program.
    During this meeting, NVAC will hear presentations to support the 
recent charges on innovation and safety from Admiral Rachel L. Levine, 
MD, the Assistant Secretary for Health and Director of the National 
Vaccine Program. NVAC will also hear presentations on the actions and 
strategies taken to better address the unique vaccination needs of 
people with disabilities, respiratory disease prevention plans for the 
upcoming fall season, and updates on climate change vaccines. Please 
note that agenda items are subject to change, as priorities dictate. 
Information on the final meeting agenda will be posted prior to the 
meeting on the NVAC website: https://www.hhs.gov/nvpo/nvac/.
    Members of the public will have the opportunity to provide comment 
at the NVAC meeting during the public comment period designated on the 
agenda. Public comments made during the meeting will be limited to 
three minutes per person to ensure time is allotted for all those 
wishing to speak. Members of the public may also submit written 
comments. Written comments should not exceed three pages in length. 
Individuals planning to submit comments should email their written 
comments or their request to provide a comment during the meeting to 
[email protected] at least five business days prior to the meeting.

    Dated: August 7, 2023.
Ann Aikin,
Acting Designated Federal Official, Office of the Assistant Secretary 
for Health.
[FR Doc. 2023-18994 Filed 9-1-23; 8:45 am]
BILLING CODE 4150-44-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.